Article
Unraveling the molecular pathophysiology of myelodysplastic syndromes.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 10 Feb 2011
Bejar Rafael, Levine Ross, Ebert Benjamin L
Abstract excerpt
Somatically acquired genetic abnormalities lead to the salient features that define myelodysplastic syndromes (MDS): clonal hematopoiesis, aberrant differentiation, peripheral cytopenias, and risk of progression to acute myeloid leukemia. Although specific karyotypic abnormalities have been linked to MDS for decades, more recent findings have demonstrated the importance of mutations within individual genes, focal...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
